IP Library Assignment 037609/0089
Patent Assignment
Reel/Frame 037609/0089

Assignment of Assignor's Interest

Recorded: 2016-01-28 Pages: 7
Assignors
ASKEW, BEN C.
Executed: 2015-12-22
GOOD, ANDREW
Executed: 2016-01-15
ONG, WINSTON ZAPANTA
Executed: 2015-12-18
NOWAK, PAWEL WOJCIECH
Executed: 2015-12-18
Assignee
KALA PHARMACEUTICALS, INC.
100 BEAVER STREET, SUITE 201, WALTHAM, MASSACHUSETTS, 02453
Covered Property (1)
Compounds for Treatment of Diseases of Abnormal Angiogenesis or Aberrant Growth Factors and Uses Thereof
Patent: 9,988,386 →
Application: 14/894,214 →
Publication: US 2016/0137646
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Oct 1, 2018
From: KALA PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 047172/0481 →
Termination and Release of Security Interest in Patents at Reel and Frame: 047602 / 0480 & 047172 / 0481 May 5, 2021
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: KALA PHARMACEUTICALS, INC
Reel/Frame 056151/0092 →
Security Interest May 6, 2021
From: KALA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 056168/0602 →
First Amendment to Ip Security Agreement Dec 22, 2022
From: KALA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 062205/0883 →
Change of Name Sep 21, 2023
From: KALA PHARMACEUTICALS, INC.
To: KALA BIO, INC.
Reel/Frame 065017/0488 →